Arthritis & Rheumatism · 1995 · 50 citations · 14 references
MedicineMicrobiologyPediatricsImmunopathologyPediatric RheumatologyVirologyInfectious DermatosesJuvenile DermatomyositisPediatric Clinical ImmunologyViral DiagnosticsViral InfectionsCoxsackievirus InfectionsMagnetic Resonance Imaging Muscle AssessmentMycoplasma InfectionsParainfluenza Virus InfectionPediatric Viral InfectionsToxoplasma DetectionToxoplasma Gondii DetectionViral Antigen Detection
OBJECTIVE: To investigate for the presence of increased titers of circulating antibody to putative infectious agents and for detectable viral RNA or bacterial DNA in children with active recent-onset juvenile dermatomyositis (DM). METHODS: Magnetic resonance imaging-directed muscle biopsies were performed in 20 children with active, untreated, recent-onset juvenile DM and in age-matched children with neurologic disease. Sera were tested for complement-fixing antibody to Coxsackievirus B (CVB), influenza A and B, parainfluenza 1 and 3, Mycoplasma pneumoniae, mumps, respiratory syncytial virus, and Reovirus; and by immunofluorescence for IgG antibody to Toxoplasma gondii cytomegalovirus and IgM antibody to Epstein-Barr virus. Muscle from juvenile DM patients and control children, CD-1 Swiss mice with and without CVB1 infection, and viral stock positive for CVB1-6 were tested using reverse-transcriptase polymerase chain reaction with 5 primer sets, 4 probes (1 Coxsackievirus, 3 Enterovirus), and universal primers for DNA. RESULTS: No increased antibody, viral RNA, or bacterial DNA was present in the juvenile DM patients or the control children. CONCLUSION: Juvenile DM may be triggered by unidentified agent(s) in the genetically susceptible host.
14
The Agent of Bacillary Angiomatosis
David A. Relman, Jeffery S. Loutit, Thomas M. Schmidt et al. · New England Journal of Medicine · 1990 · 898 citations · Full text